ANAPTYSBIO, INC ANAB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-01-26
ANAPTYSBIO, INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,769,944 | $44.4M |
| D. E. Shaw & Co., Inc. | 579,296 | $32.1M |
| MILLENNIUM MANAGEMENT LLC | 475,572 | $26.4M |
| TWO SIGMA INVESTMENTS, LP | 465,083 | $25.8M |
| CITADEL ADVISORS LLC | 241,150 | $13.4M |
| RENAISSANCE TECHNOLOGIES LLC | 90,900 | $5.0M |
| Point72 Asset Management, L.P. | 55,303 | $3.1M |
| AQR CAPITAL MANAGEMENT LLC | 32,467 | $1.8M |
Source: SEC EDGAR filings · CIK 0001370053 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.